Cargando…

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma

BACKGROUND: The serine peptidase inhibitor Kazal type 13 (SPINK13) gene has tumor suppressor activity, but its role in renal cell carcinoma (RCC) remains unknown. This study aimed to investigate mRNA expression of SPINK13 in clear cell renal cell carcinoma (CCRCC) in human tissue and to use bioinfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wen-Hao, Shi, Shen-Nan, Wang, Jun, Xu, Yue, Tian, Xi, Wan, Fang-Ning, Cao, Da-Long, Qu, Yuan-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926094/ https://www.ncbi.nlm.nih.gov/pubmed/31825950 http://dx.doi.org/10.12659/MSM.917754

Ejemplares similares

Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes
por: Le, Ngoc Anh, et al.
Publicado: (2014)

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
por: Räsänen, Kati, et al.
Publicado: (2017)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2019)

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant
por: Buchholz, Ina, et al.
Publicado: (2020)

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
por: Gasiorowska, Anita, et al.
Publicado: (2010)

Kazal-type serine proteinase inhibitors in the midgut of Phlebotomus papatasi
por: Sigle, Leah Theresa, et al.
Publicado: (2013)

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
por: Chen, Yi-Ting, et al.
Publicado: (2022)

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis
por: Sun, Chang, et al.
Publicado: (2015)

Transcriptome analysis of the effect of a novel human serine protease inhibitor SPINK13 on gene expression in MHCC97-H cells
por: Wei, Ling, et al.
Publicado: (2021)

Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
por: Sumiya, Ryusuke, et al.
Publicado: (2023)

Generation and Analysis of Serine Protease Inhibitor Kazal Type 3-Cre Driver Mice
por: Sakata, Kazuya, et al.
Publicado: (2014)

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action
por: Ge, Kuikui, et al.
Publicado: (2016)

SPINK6 inhibits human airway serine proteases and restricts influenza virus activation
por: Wang, Dong, et al.
Publicado: (2021)

Temporary serine protease inhibition and the role of SPINK2 in human bone marrow
por: Barresi, Vincenza, et al.
Publicado: (2023)

Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis
por: Li, Yunling, et al.
Publicado: (2020)

[2] Families of serine peptidases
por: Rawlings, Neil D., et al.
Publicado: (1994)

Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases
por: Zhu, Chengliang, et al.
Publicado: (2019)

A Kazal-Type Serine Protease Inhibitor from the Defense Gland Secretion of the Subterranean Termite Coptotermes formosanus Shiraki
por: Negulescu, Horia, et al.
Publicado: (2015)

Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma
por: Lu, Felix, et al.
Publicado: (2020)

Performance of SPINK1 and SPINK1‐based diagnostic model in detection of hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor
por: Meyer-Hoffert, Ulf, et al.
Publicado: (2009)

Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
por: Qian, Cen, et al.
Publicado: (2015)

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis
por: Ohmuraya, Masaki, et al.
Publicado: (2012)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family
por: Tian, Miaoying, et al.
Publicado: (2005)

Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Targeting an autocrine IL-6 – SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2020)

Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin
por: Shenoy, Rajesh T., et al.
Publicado: (2011)

High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes
por: Kolly, Anish, et al.
Publicado: (2017)

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
por: Kulke, Martin, et al.
Publicado: (2021)

An Essential Signal Peptide Peptidase Identified in an RNAi Screen of Serine Peptidases of Trypanosoma brucei
por: Moss, Catherine X., et al.
Publicado: (2015)

Adaptation of Helicoverpa armigera to Soybean Peptidase Inhibitors Is Associated with the Transgenerational Upregulation of Serine Peptidases
por: Velasquez-Vasconez, Pedro A., et al.
Publicado: (2022)

Sugarcane Serine Peptidase Inhibitors, Serine Peptidases, and Clp Protease System Subunits Associated with Sugarcane Borer (Diatraea saccharalis) Herbivory and Wounding
por: Medeiros, Ane H., et al.
Publicado: (2016)

Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
por: Dai, Siyuan, et al.
Publicado: (2021)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma
por: Jia, Jianlong, et al.
Publicado: (2022)

Plasma Cell Cheilitis: A Clinicopathological and Immunohistochemical Study of 13 Cases
por: Lee, Jin Yong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a464kfjd3sso6ebsftho17uog5